1. Home
  2. SGMO vs TSE Comparison

SGMO vs TSE Comparison

Compare SGMO & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.44

Market Cap

155.1M

Sector

Health Care

ML Signal

HOLD

Logo Trinseo PLC

TSE

Trinseo PLC

HOLD

Current Price

$0.47

Market Cap

68.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGMO
TSE
Founded
1995
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
155.1M
68.0M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
SGMO
TSE
Price
$0.44
$0.47
Analyst Decision
Buy
Hold
Analyst Count
7
1
Target Price
$4.71
$1.00
AVG Volume (30 Days)
6.1M
826.3K
Earning Date
11-06-2025
02-11-2026
Dividend Yield
N/A
6.22%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$32,875,000.00
$3,133,800,000.00
Revenue This Year
$1.37
N/A
Revenue Next Year
N/A
$4.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$0.46
52 Week High
$2.73
$5.99

Technical Indicators

Market Signals
Indicator
SGMO
TSE
Relative Strength Index (RSI) 43.82 25.92
Support Level $0.43 $0.46
Resistance Level $0.49 $0.52
Average True Range (ATR) 0.03 0.07
MACD 0.00 0.01
Stochastic Oscillator 10.29 4.76

Price Performance

Historical Comparison
SGMO
TSE

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

Share on Social Networks: